When public health becomes an ownership question.
The corporatisation of New Zealand healthcare is no longer a side issue - it is quietly resetting who owns care, who shapes it, and who benefits from it.
The risk is that, in prioritising the corporate goals of efficiency and growth, the publicly funded health system drifts away from relationships, continuity, and community - the very things that keep people well.
At the heart of this story is a simple tension: public money is being channeled through private structures whose primary duty is not always to patients or communities, but to owners and shareholders.
How we design and regulate those structures will determine whether the next decade of reform strengthens or hollows out New Zealanders’ health.
The ownership continuum: who really benefits?
At one end sit public and not‑for‑profit providers - public hospitals and not‑for‑profit operators such as Southern Cross Healthcare and kaupapa Māori services. Their mandate is service, equity, and long‑term wellbeing.
Surpluses go back into facilities, services, and communities, not into dividends. These providers often stand where the market will not - in high‑needs, low‑margin, complex spaces.
At the opposite end are the corporate ownership structures. Groups like The Doctors, Tend, Tamaki Health, Lumino Dentists, Habit Health, Awanui Labs, Chemist Warehouse, Woolworths Pharmacies, and large home‑care and aged‑care operators such as Access Community Health, Ryman and Metlifecare.
Strategy is centralised, protocols are standardised, and success is measured in network growth and financial performance. These organisations can bring capital, technology, and reach. But they do it by turning care into a system that must constantly move faster and cheaper.
That’s where the contradictions show: [1]
Home healthcare workers and rest‑home staff are asked to provide intimate, emotionally heavy care on low or near‑minimum wages.
Appointment times are squeezed.
Front‑line workers feel the weight of KPIs they did not set.
Community and Maori health equity suffers.
The client facing the worker in the clinical consultation room or the resident in the rest home is not thinking about EBITDA, but the system around them is.
1. Corporate Ownership of Health Providers in New Zealand. Ownership structures, reduced local control, and community impact. April 2025.
The mixed model: Public funding + locally-owned private providers
At the most local end are independent owner‑operators such as pharmacist-owned community pharmacies and GP practices whose owners still consult in their own rooms.
These business owners employ local staff, sponsor local sports teams, and see their patients in the supermarket. Their business decisions and their clinical ethics are the same conversation.
In order to be heard these small businesses need to band together in associations, co‑operatives, marketing groups, and franchises. Pharmacy collectives like ICPG and GP organisations such as GenPro use the scale of their membership base for national negotiations, data collection, and service development, but keep ownership and control in the hands of local clinicians and operators. Any fee surplus is recycled into services, advocacy, and support for members rather than flowing offshore.
Pharmacy deregulation: the fault line in front of us
The coming deregulation of pharmacy ownership is the clearest test of which side of this continuum New Zealand really wants to back. Associate Health Minister and former Hobson’s Pledge spokesperson, Casey Costello, is backing the new Medical Products Bill which aims to deregulate pharmacy ownership so that anyone (or any company) can own as many pharmacies as they like.
On one side, the argument for change: current ownership rules are called “antiquated” and corporate workarounds already exist. Loosening the rules, the story goes, will allow more innovation, more investment, and new integrated models where prescribers and pharmacies sit under common ownership.
On the other side sit the independent voices; ICPG, the Pharmaceutical Society, Māori and public‑health advocates - pointing to both New Zealand case law and overseas experience. [2]
Where countries have deregulated, the pattern is familiar:
chains and vertically integrated wholesaler‑owners quickly dominate
new pharmacies cluster in busy urban locations; rural and high‑needs areas often see little net gain
professional independence erodes as head offices set the tempo
time for counselling shrinks
the owner is no longer the health professional behind the counter; they are somewhere in a boardroom, reading a dashboard.
The people who feel that shift first are the most high‑needs New Zealanders. The older person who relies on a local pharmacist who knows their history. The whānau managing multiple conditions on a tight budget. The rural community where one small pharmacy is the difference between access and nothing.
If deregulation simply opens the door wider to corporate chains, those are the communities at greatest risk of being left with thinner, less personalised, more fragile services. Or none at all as the sustainability of locally-owned pharmacy margins are further eroded.
The quiet costs of “bigger”
Bigger and privately-owned is not automatically bad. Large diagnostic and primary‑care networks can use technology and process to lift minimum standards. Private surgical providers like Kaweka and Intus can offer high‑quality, timely care where the public system is struggling.
The danger is the unintended consequence: a system that looks efficient on a spreadsheet but feels colder and more distant in people’s lives.
Shorter consults.
Fewer familiar faces.
More care delivered by underpaid workers under pressure.
Growing gaps between those who can navigate or pay their way to better options and those who cannot.
When ownership moves further away from the communities being served, the ability to “go the extra mile” - to spend a bit more time, to subsidise, to quietly do the right thing - tends to move with it.
Why strong advocacy matters NOW
This is why strong, organised, sector‑led advocacy is no longer optional.
Groups like ICPG, Kaitiaki Hauora, GenPro and Māori health organisations, professional bodies, and health‑sector unions are the voice of the people at the coalface; the GPs, pharmacists, nurses, kaiāwhina, carers, and home‑care workers whose daily work turns policy into reality.
Their job is to hold a clear line on three things:
Ownership and control must not be allowed to drift so far from practice that commercial targets routinely trump clinical judgment.
Funding and regulation must recognise the full value of local, relationship‑based care - not just the cheapest way to process volume.
The communities with the highest needs must not be left carrying the heaviest costs of “efficiency” and “deregulation”.
The future of New Zealanders’ health will not be decided by one Bill or one contract round. It will be shaped by the cumulative effect of ownership, funding, and workforce decisions made over the next few years.
If those decisions are left to pure commercial logic, bigger and more centralised will win, and the system will become less human, less local, and ultimately less effective.
The counterweight has to come from the people and organisations whose careers are built on care, not on quarterly results.
If their voices are strong, organised, and impossible to ignore, New Zealand still has time to build a health system where commercial structures exist to serve communities - not the other way around.
